臻鐳科技(688270.SH):擬以自有資金對全資子公司城芯科技、航芯源進行增資
格隆匯3月28日丨臻鐳科技(688270.SH)公佈,爲增強全資子公司城芯科技和航芯源的綜合競爭力,滿足客戶端對供應商註冊資金、資產負債率等資質不斷提升的要求,並補充全資子公司流動資金,公司擬以自有資金2,000萬元對城芯科技進行增資,其中400萬元計入註冊資本,剩餘1,600萬元列入資本公積,增資完成後,城芯科技註冊資本由8,000萬元增加至8,400萬元;公司擬以自有資金2,000萬元對航芯源進行增資,其中900萬元計入註冊資本,剩餘1,100萬元列入資本公積,增資完成後,航芯源註冊資本由7,000萬元增加至7,900萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.